Technical Analysis for PRVB - Provention Bio, Inc.

Grade Last Price % Change Price Change
grade F 2.2 -0.90% -0.02
PRVB closed down 0.9 percent on Friday, February 15, 2019, on 48 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical PRVB trend table...

Date Alert Name Type % Chg
Feb 15 50 DMA Resistance Bearish 0.00%
Feb 15 MACD Bearish Centerline Cross Bearish 0.00%
Feb 15 Earnings Movers Other 0.00%
Feb 14 Fell Below 50 DMA Bearish -0.90%
Feb 14 180 Bearish Setup Bearish Swing Setup -0.90%
Feb 14 Earnings Movers Other -0.90%
Feb 14 Inside Day Range Contraction -0.90%
Feb 13 Bullish Engulfing Bullish -7.17%
Feb 13 Crossed Above 50 DMA Bullish -7.17%
Feb 13 Lower Bollinger Band Touch Weakness -7.17%

Older signals for PRVB ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Provention Bio, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics targeting immune-mediated diseases. The Company aims at developing therapies for disease that include type one diabetes (T1D), Crohn’s disease, ulcerative colitis, lupus and other viral diseases. The Company’s principal product candidates include PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-0101.PRV-031 is a product candidate in its Phase III clinical trial that is developed for the interception of T1D. PRV-6527 is an oral CSF-1R inhibitor for the treatment of Crohn’s disease. PRV-300 is developed for the treatment of ulcerative colitis. PRV-3279 is developed to treat lupus disease. PRV-101 is a multivalent coxsackie virus (CVB) vaccine for the prevention of acute CVB and the prevention of the onset of T1D.
Medicine Biopharmaceutical Medical Specialties Immunology Diabetes Disease Autoimmune Diseases Ulcerative Colitis Abdominal Pain Diarrhea Crohn's Disease Viral Diseases Colitis Lupus Immune Mediated Diseases
Is PRVB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.0
52 Week Low 1.52
Average Volume 47,533
200-Day Moving Average 0.0
50-Day Moving Average 2.2659
20-Day Moving Average 2.3895
10-Day Moving Average 2.349
Average True Range 0.207
ADX 17.98
+DI 13.5177
-DI 21.1139
Chandelier Exit (Long, 3 ATRs ) 2.139
Chandelier Exit (Short, 3 ATRs ) 2.481
Upper Bollinger Band 2.6185
Lower Bollinger Band 2.1605
Percent B (%b) 0.09
BandWidth 19.16719
MACD Line -0.011
MACD Signal Line 0.017
MACD Histogram -0.028
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.40
Resistance 3 (R3) 2.42 2.37 2.36
Resistance 2 (R2) 2.37 2.32 2.36 2.35
Resistance 1 (R1) 2.29 2.29 2.27 2.27 2.34
Pivot Point 2.24 2.24 2.23 2.23 2.24
Support 1 (S1) 2.16 2.19 2.14 2.14 2.06
Support 2 (S2) 2.11 2.16 2.10 2.05
Support 3 (S3) 2.03 2.11 2.04
Support 4 (S4) 2.01